Houtai Choumane
Dr. Houtai Choumane has led KiOmed Pharma as CEO and Managing Director since its founding in 2014. He brings nearly 20 years of experience in product development, executive management, and business development for innovative biotech companies. KiOmed Pharma is a spin-off from Kitozyme, a world-leading manufacturer of vegetable chitosan.
The company's core technology, KiOmedine, is an animal-free biodegradable biopolymer positioned as an alternative to hyaluronic acid for treating osteoarthritis. Its flagship product KioMedine-vs-one received approval from the Chinese FDA and the company has signed an exclusive partnership with Sinclair Pharma.
Career
Roles
KiOmed PharmaCEO & Managing DirectorMar 2014 – Present
- ArtialisCEOJun 2012 – May 2014
- GenewaveCEOAug 2007 – Sep 2010
- European commission, GenewaveR&D Project ManagerOct 2002 – Jul 2007
- Alcatel-Lucent EnterprisePhD ResearcherSep 1999 – Sep 2002
Education
- Babson College#260schoolMajor in Innovation and Entrepreneurship, Innovation and Entrepreneurship2011 - 2012
HEC Paris#48schoolExecutive Master of Business Administration (EMBA), Innovation and Entrepreneurship2010 - 2012
- Ecole normale supérieure /University ORSAYDoctor of Philosophy (PhD), Photonics1999 - 2002
From public career histories · 8 entries